Floatz logo

SUFENTANYL

Chronic Postoperative Pain

Aydin Adnan Menderes UniversitySmall moleculeEarly Phase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the Chronic Postoperative Pain cohort.

Asset / SponsorPhaseRating
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Imperial College Healthcare NHS Trust
Phase 4BB
Bxcl501
Zhongda Hospital
Phase 4BB
Pregabalin
Unity Health Toronto
Phase 4BB
Buprenorphine
Medical University of Silesia
Phase 4BB
Oxycodone
Medical University of Silesia
Phase 4BB

View all 16 →

Same molecule, other indications

SUFENTANYL is also rated in:

chronic pain syndromeDormant
BB
Indicative ·
69 / 100
View asset →
AnalgesicsDormant
BB
Indicative ·
68 / 100
View asset →
Post Operative PainDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →